NZ329696A - Use of isolated peptides derived from mage tumour rejection antigen precursors which complex with hla a2 molecules in treating cancer - Google Patents

Use of isolated peptides derived from mage tumour rejection antigen precursors which complex with hla a2 molecules in treating cancer

Info

Publication number
NZ329696A
NZ329696A NZ329696A NZ32969695A NZ329696A NZ 329696 A NZ329696 A NZ 329696A NZ 329696 A NZ329696 A NZ 329696A NZ 32969695 A NZ32969695 A NZ 32969695A NZ 329696 A NZ329696 A NZ 329696A
Authority
NZ
New Zealand
Prior art keywords
hla
molecules
complex
treating cancer
peptides derived
Prior art date
Application number
NZ329696A
Inventor
Alan Townsend
Judy Bastin
Thierry Boon-Falleur
Der Bruggen Pierre Van
Pierre Coulie
Thomas Gajewski
Cornelis J M Melief
M W Visseren
W M Kast
Original Assignee
Ludwig Inst Cancer Res
Univ Oxford
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/217,186 external-priority patent/US5585461A/en
Priority claimed from US08/290,381 external-priority patent/US5851523A/en
Application filed by Ludwig Inst Cancer Res, Univ Oxford, Univ Leiden filed Critical Ludwig Inst Cancer Res
Publication of NZ329696A publication Critical patent/NZ329696A/en

Links

NZ329696A 1994-03-24 1995-03-22 Use of isolated peptides derived from mage tumour rejection antigen precursors which complex with hla a2 molecules in treating cancer NZ329696A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/217,186 US5585461A (en) 1994-03-24 1994-03-24 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US08/261,160 US5591430A (en) 1994-03-24 1994-06-17 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US08/290,381 US5851523A (en) 1994-03-24 1994-08-15 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
NZ283587A NZ283587A (en) 1994-03-24 1995-03-22 Isolated peptides derived from mage tumour rejection antigen precursors which complex with hla-a2 and their use

Publications (1)

Publication Number Publication Date
NZ329696A true NZ329696A (en) 1999-02-25

Family

ID=27484350

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ329696A NZ329696A (en) 1994-03-24 1995-03-22 Use of isolated peptides derived from mage tumour rejection antigen precursors which complex with hla a2 molecules in treating cancer

Country Status (1)

Country Link
NZ (1) NZ329696A (en)

Similar Documents

Publication Publication Date Title
ZA952374B (en) Isolated peptides derived from MAGE antigen precursors which complex with HLA-A2 molecules and uses thereof
EP0831905A4 (en) Methods of treating colon cancer utilizing tumor-specific antibodies
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU7079396A (en) Anti-galalpha(1,3)gal antibody binding peptides
EP1001807A4 (en) Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
IL109092A (en) Tumor suppressor gene, protein expressed thereby, vectors containing said gene, and use of said vector and protein in cancer treatment
HUP0002095A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
BR9508886A (en) Compounds and methods for the treatment of cancer
EP0831880A4 (en) Antibody and antibody fragments for inhibiting the growth of tumors
NO963918L (en) Isolated peptides derived from the tumor rejection precursor MAGE-2, and their use
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
HK1041025A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
HUP0004326A3 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
EP0708592A4 (en) Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
DE69534325D1 (en) PEPTIDES FOR THE TREATMENT OF CANCER
IL114119A0 (en) Compositions and methods for the treatment of tumors
NZ331398A (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
NZ329696A (en) Use of isolated peptides derived from mage tumour rejection antigen precursors which complex with hla a2 molecules in treating cancer
ATE316574T1 (en) USE OF ULIP PROTEINS FOR THE DIAGNOSIS AND THERAPY OF CANCER AND PARANEOPLASTIC NEUROLOGICAL SYNDROME
EP0951475A4 (en) Metastatic colorectal cancer vaccine
NZ306122A (en) Rage tumour rejection antigen precursors, diagnosis and treatment thereby
EP0876507A4 (en) Manipulation and detection of protein phosphatase 2c - pp2c alpha- expression in tumor cells for cancer therapy, prevention and detection
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer